ArticleJournal of nanobiotechnology2006
C60-fullerenes: detection of intracellular photoluminescence and lack of cytotoxic effects.
Article in Journal of nanobiotechnology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 109 citations in OpenAlex.
- Insight into the interactions of fullerenes with biological membranes through molecular dynamics simulations.Advances in physics: X · 2024Article
- Comparison of Sonodynamic Treatment Set-Ups for Cancer Cells with Organic Sonosensitizers and Nanosonosensitizers.Pharmaceutics · 2023Article
- Silent Death by Sound: CInternational journal of molecular sciences · 2023Article
- Carbon Nanostructures, Nanolayers, and Their Composites.Nanomaterials (Basel, Switzerland) · 2021Review
- Antagonistic Interactions between Benzo[a]pyrene and Fullerene (CNanomaterials (Basel, Switzerland) · 2019Article
- Mechano-signalling, induced by fullerene CInternational journal of nanomedicine · 2019Article
- Exploring the Inhibitory and Antioxidant Effects of Fullerene and Fullerenol on Ribonuclease A.ACS omega · 2018Article
- CNanoscale research letters · 2018Article
- Fullerene CNanoscale research letters · 2017Article
- Article
- Phytosynthesis of nanoparticles: concept, controversy and application.Nanoscale research letters · 2014Article
- Photodynamic therapy with fullerenes in vivo: reality or a dream?Nanomedicine (London, England) · 2011Article
- Modulation of adenosine receptors by [60]fullerene hydrosoluble derivative in SK-N-MC cells.ACS chemical neuroscience · 2011Article
- Nanotoxicology and nanoparticle safety in biomedical designs.International journal of nanomedicine · 2011Review
- Does aqueous fullerene inhibit the growth of Saccharomyces cerevisiae or Escherichia coli?Applied and environmental microbiology · 2010Article
- Ecotoxicity of engineered nanoparticles to aquatic invertebrates: a brief review and recommendations for future toxicity testing.Ecotoxicology (London, England) · 2008Review
- Fullerene C60 exposure elicits an oxidative stress response in embryonic zebrafish.Toxicology and applied pharmacology · 2008Article
- Photodynamic therapy with fullerenes.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2007Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
We have developed a new method of application of C60 to cultured cells that does not require water-solubilization techniques. Normal and malignant cells take-up C60 and the inherent photoluminescence of C60 is detected within multiple cell lines. Treatment of cells with up to 200 microg/ml (200 ppm) of C60 does not alter morphology, cytoskeletal organization, cell cycle dynamics nor does it inhibit cell proliferation. Our work shows that pristine C60 is non-toxic to the cells, and suggests that fullerene-based nanocarriers may be used for biomedical applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.